Page last updated: 2024-12-10
delta(3)-hexadecenoic acid
Description
delta(3)-hexadecenoic acid: RN given refers to cpd without isomeric designation [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
(3E)-3-hexadecenoic acid : A hexadecenoic acid having a trans-double bond at the 3-position. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]
Cross-References
ID Source | ID |
PubMed CID | 5312418 |
CHEBI ID | 142241 |
SCHEMBL ID | 407961 |
SCHEMBL ID | 407960 |
MeSH ID | M0193032 |
Synonyms (19)
Synonym |
2457-70-7 |
3-hexadecenoic acid |
LMFA01030266 |
3e-hexadecenoic acid |
hexadec-3-enoic acid |
(3e)-hexadec-3-enoic acid |
(3e)-3-hexadecenoic acid |
CHEBI:142241 |
(e)-hexadec-3-enoic acid |
1686-10-8 |
3-hexadecenoic acid, (3e)- |
delta(3)-hexadecenoic acid |
nsc 33747 |
trans-3-hexadecenoic acid |
SCHEMBL407961 |
SCHEMBL407960 |
DTXSID701312588 |
BAA68610 |
EN300-22859351 |
Roles (1)
Role | Description |
plant metabolite | Any eukaryotic metabolite produced during a metabolic reaction in plants, the kingdom that include flowering plants, conifers and other gymnosperms. |
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Drug Classes (1)
Class | Description |
hexadecenoic acid | A C16 straight-chain monounsaturated fatty acid having one C=C double bond. |
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Research
Studies (5)
Timeframe | Studies, This Drug (%) | All Drugs % |
pre-1990 | 1 (20.00) | 18.7374 |
1990's | 3 (60.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 12.80
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
Metric | This Compound (vs All) |
---|
Research Demand Index | 12.80 (24.57) | Research Supply Index | 1.79 (2.92) | Research Growth Index | 4.59 (4.65) | Search Engine Demand Index | 0.00 (26.88) | Search Engine Supply Index | 0.00 (0.95) |
| |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 5 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |